Treatment of longstanding active giant cell arteritis with infliximab: Report of four cases

Arthritis and Rheumatism

Volumn 44, Issue 12, 2001, Pages 2933-2935

  Cantini, Fabrizio ^a   Niccoli, Laura ^a   Salvarani, Carlo ^b   Padula, Angela ^c   Olivieri, Ignazio ^c  

^a MISERICORDIA E DOLCE HOSPITAL   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c SAN CARLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; INFLIXIMAB; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CASE REPORT; CATARACT; DIABETES MELLITUS; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GIANT CELL ARTERITIS; HUMAN; MALE; OSTEOPOROSIS; PRIORITY JOURNAL;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; MALE; REMISSION INDUCTION; TEMPORAL ARTERITIS;

EID: 0035674050     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO;2-Y     Document Type: Article

References (14)

1. Giant cell arteritis and polymyalgia rheumatica
2. Polymyalgia rheumatica
3. Analysis of steroid related complications and mortality in temporal arteritis: A 15-year survey of 43 patients
4. Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica
5. Steroid sparing therapeutic approaches to polymyalgia rheumatica-giant cell arteritis: State of art and perspectives
6. Tissue cytokine patterns in polymyalgia rheumatica and giant cell arteritis
7. The acute phase response
8. Immuno-localisation of tumor necrosis factor and its receptors in temporal arteritis
9. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms
10. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
11. Infliximab (chimeric anti-tumor necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
12. Effects of a loading dose of three infusions of chimeric monoclonal antibody to tumor necrosis factor a (infliximab) in spondylarthropathy: An open pilot study
13. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor α monoclonal antibody infliximab
14. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis